Rank | Gene Set | Z-score |
---|---|---|
1 | sulfur amino acid catabolic process (GO:0000098) | 6.06538559 |
2 | desmosome organization (GO:0002934) | 6.04583672 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.26660422 |
4 | L-phenylalanine catabolic process (GO:0006559) | 5.26660422 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.19326399 |
6 | L-phenylalanine metabolic process (GO:0006558) | 5.19326399 |
7 | bile acid and bile salt transport (GO:0015721) | 5.03675534 |
8 | intestinal cholesterol absorption (GO:0030299) | 4.90246653 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.72546299 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 4.62709056 |
11 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.62247460 |
12 | cysteine metabolic process (GO:0006534) | 4.59538329 |
13 | ear development (GO:0043583) | 4.51123267 |
14 | high-density lipoprotein particle remodeling (GO:0034375) | 4.31437453 |
15 | urea cycle (GO:0000050) | 4.29063068 |
16 | urea metabolic process (GO:0019627) | 4.29063068 |
17 | epoxygenase P450 pathway (GO:0019373) | 4.25052233 |
18 | intestinal absorption (GO:0050892) | 4.23738370 |
19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.19784267 |
20 | flavonoid metabolic process (GO:0009812) | 4.19043079 |
21 | cellular glucuronidation (GO:0052695) | 4.15228968 |
22 | multicellular organismal water homeostasis (GO:0050891) | 4.14810235 |
23 | indole-containing compound catabolic process (GO:0042436) | 4.13838774 |
24 | indolalkylamine catabolic process (GO:0046218) | 4.13838774 |
25 | tryptophan catabolic process (GO:0006569) | 4.13838774 |
26 | kynurenine metabolic process (GO:0070189) | 4.08223685 |
27 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.06163889 |
28 | NADH metabolic process (GO:0006734) | 4.06109799 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 4.05173908 |
30 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.00837156 |
31 | vitamin transmembrane transport (GO:0035461) | 3.99428452 |
32 | axonemal dynein complex assembly (GO:0070286) | 3.99324251 |
33 | regulation of water loss via skin (GO:0033561) | 3.98958098 |
34 | homocysteine metabolic process (GO:0050667) | 3.98646729 |
35 | reverse cholesterol transport (GO:0043691) | 3.97969466 |
36 | regulation of cholesterol esterification (GO:0010872) | 3.97812037 |
37 | GDP-mannose metabolic process (GO:0019673) | 3.96559932 |
38 | nitrogen cycle metabolic process (GO:0071941) | 3.92913857 |
39 | ethanol metabolic process (GO:0006067) | 3.92699060 |
40 | bile acid biosynthetic process (GO:0006699) | 3.92304074 |
41 | bile acid metabolic process (GO:0008206) | 3.92161344 |
42 | phospholipid efflux (GO:0033700) | 3.89713791 |
43 | uronic acid metabolic process (GO:0006063) | 3.89183051 |
44 | glucuronate metabolic process (GO:0019585) | 3.89183051 |
45 | alpha-linolenic acid metabolic process (GO:0036109) | 3.88612032 |
46 | tryptophan metabolic process (GO:0006568) | 3.85516694 |
47 | negative regulation of sterol transport (GO:0032372) | 3.84944606 |
48 | negative regulation of cholesterol transport (GO:0032375) | 3.84944606 |
49 | plasma lipoprotein particle remodeling (GO:0034369) | 3.84345103 |
50 | protein-lipid complex remodeling (GO:0034368) | 3.84345103 |
51 | macromolecular complex remodeling (GO:0034367) | 3.84345103 |
52 | triglyceride homeostasis (GO:0070328) | 3.81986643 |
53 | acylglycerol homeostasis (GO:0055090) | 3.81986643 |
54 | epithelial cell-cell adhesion (GO:0090136) | 3.80359890 |
55 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.80007424 |
56 | primary alcohol catabolic process (GO:0034310) | 3.78926182 |
57 | negative regulation of fibrinolysis (GO:0051918) | 3.78275635 |
58 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77696989 |
59 | drug catabolic process (GO:0042737) | 3.77445016 |
60 | glyoxylate metabolic process (GO:0046487) | 3.76019369 |
61 | response to nitrosative stress (GO:0051409) | 3.75443473 |
62 | amyloid precursor protein catabolic process (GO:0042987) | 3.72405908 |
63 | complement activation, alternative pathway (GO:0006957) | 3.72101500 |
64 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.71086990 |
65 | ethanol oxidation (GO:0006069) | 3.70530650 |
66 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.69967514 |
67 | hepatocyte apoptotic process (GO:0097284) | 3.68148819 |
68 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.66184566 |
69 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.65368377 |
70 | regulation of cholesterol homeostasis (GO:2000188) | 3.65083589 |
71 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.63604372 |
72 | protein carboxylation (GO:0018214) | 3.63604372 |
73 | Golgi transport vesicle coating (GO:0048200) | 3.62183021 |
74 | COPI coating of Golgi vesicle (GO:0048205) | 3.62183021 |
75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62157844 |
76 | amino-acid betaine metabolic process (GO:0006577) | 3.59868123 |
77 | establishment of apical/basal cell polarity (GO:0035089) | 3.57525059 |
78 | regulation of protein activation cascade (GO:2000257) | 3.56037026 |
79 | angiotensin maturation (GO:0002003) | 3.56017545 |
80 | response to food (GO:0032094) | 3.55583141 |
81 | * calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.53338659 |
82 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.51949375 |
83 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.51656132 |
84 | regulation of fibrinolysis (GO:0051917) | 3.49884978 |
85 | glutathione biosynthetic process (GO:0006750) | 3.47086091 |
86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46022551 |
87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46022551 |
88 | cellular ketone body metabolic process (GO:0046950) | 3.45734654 |
89 | cellular modified amino acid catabolic process (GO:0042219) | 3.42749870 |
90 | cholesterol efflux (GO:0033344) | 3.42420794 |
91 | cholesterol homeostasis (GO:0042632) | 3.40424577 |
92 | aromatic amino acid family metabolic process (GO:0009072) | 3.39563643 |
93 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.39551281 |
94 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.39319294 |
95 | water homeostasis (GO:0030104) | 3.36760033 |
96 | positive regulation of pseudopodium assembly (GO:0031274) | 3.36658050 |
97 | serine family amino acid catabolic process (GO:0009071) | 3.36336098 |
98 | regulation of guanylate cyclase activity (GO:0031282) | 3.35773661 |
99 | sterol homeostasis (GO:0055092) | 3.35671967 |
100 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.34767352 |
101 | regulation of complement activation (GO:0030449) | 3.34492094 |
102 | phospholipid homeostasis (GO:0055091) | 3.34248994 |
103 | fructose metabolic process (GO:0006000) | 3.31515715 |
104 | regulation of viral release from host cell (GO:1902186) | 3.31295685 |
105 | renal system process involved in regulation of blood volume (GO:0001977) | 3.30608103 |
106 | interferon-gamma secretion (GO:0072643) | 3.30130161 |
107 | striated muscle atrophy (GO:0014891) | 3.29337079 |
108 | lipoprotein metabolic process (GO:0042157) | 3.29070405 |
109 | regulation of cholesterol metabolic process (GO:0090181) | 3.29051501 |
110 | proline biosynthetic process (GO:0006561) | 3.25121201 |
111 | plasma lipoprotein particle assembly (GO:0034377) | 3.23071753 |
112 | low-density lipoprotein particle remodeling (GO:0034374) | 3.22431161 |
113 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.21078741 |
114 | establishment of skin barrier (GO:0061436) | 3.20663979 |
115 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.18804048 |
116 | glomerular filtration (GO:0003094) | 3.17666408 |
117 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.17516721 |
118 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.17174987 |
119 | intestinal epithelial cell development (GO:0060576) | 3.15884993 |
120 | benzene-containing compound metabolic process (GO:0042537) | 3.15412242 |
121 | plasma lipoprotein particle clearance (GO:0034381) | 3.14909718 |
122 | endothelial cell chemotaxis (GO:0035767) | 3.14868617 |
123 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.12861569 |
124 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.12861569 |
125 | maternal placenta development (GO:0001893) | 3.12632447 |
126 | xenobiotic catabolic process (GO:0042178) | 3.11799246 |
127 | transcytosis (GO:0045056) | 3.11703985 |
128 | acute-phase response (GO:0006953) | 3.09817602 |
129 | drug metabolic process (GO:0017144) | 3.09599165 |
130 | lysine metabolic process (GO:0006553) | 3.08697064 |
131 | lysine catabolic process (GO:0006554) | 3.08697064 |
132 | exogenous drug catabolic process (GO:0042738) | 3.07396213 |
133 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.07166258 |
134 | regulation of respiratory burst (GO:0060263) | 3.06707102 |
135 | oligosaccharide biosynthetic process (GO:0009312) | 3.06435347 |
136 | O-glycan processing (GO:0016266) | 3.05774921 |
137 | cellular amino acid catabolic process (GO:0009063) | 3.05286782 |
138 | positive regulation of lipid catabolic process (GO:0050996) | 3.04840989 |
139 | positive regulation of respiratory burst (GO:0060267) | 3.03684472 |
140 | motile cilium assembly (GO:0044458) | 3.03569281 |
141 | negative regulation of lipase activity (GO:0060192) | 3.03466640 |
142 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.03181294 |
143 | regulation of extracellular matrix disassembly (GO:0010715) | 3.02586282 |
144 | alpha-amino acid catabolic process (GO:1901606) | 3.01962208 |
145 | drug transmembrane transport (GO:0006855) | 3.01862669 |
146 | renal filtration (GO:0097205) | 3.01395865 |
147 | protein retention in ER lumen (GO:0006621) | 3.01120347 |
148 | aldehyde catabolic process (GO:0046185) | 3.00484508 |
149 | tight junction assembly (GO:0070830) | 3.00440158 |
150 | tyrosine metabolic process (GO:0006570) | 3.00199291 |
151 | surfactant homeostasis (GO:0043129) | 3.00088445 |
152 | positive regulation of fatty acid oxidation (GO:0046321) | 2.99322857 |
153 | short-chain fatty acid metabolic process (GO:0046459) | 2.98583943 |
154 | regulation of interleukin-13 production (GO:0032656) | 2.94349891 |
155 | regulation of pseudopodium assembly (GO:0031272) | 2.94261882 |
156 | sphingomyelin metabolic process (GO:0006684) | 2.94158903 |
157 | mammary gland epithelial cell differentiation (GO:0060644) | 2.91600705 |
158 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.91126469 |
159 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.90540490 |
160 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.89902191 |
161 | endocrine process (GO:0050886) | 2.89902191 |
162 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.89902191 |
163 | glucose 6-phosphate metabolic process (GO:0051156) | 2.88627187 |
164 | skeletal muscle adaptation (GO:0043501) | 2.87441757 |
165 | amyloid precursor protein metabolic process (GO:0042982) | 2.84647464 |
166 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.84331702 |
167 | establishment of monopolar cell polarity (GO:0061162) | 2.81333628 |
168 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.81333628 |
169 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.80434801 |
170 | auditory receptor cell differentiation (GO:0042491) | 2.80169802 |
171 | epithelial structure maintenance (GO:0010669) | 2.78792543 |
172 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.78486945 |
173 | proline metabolic process (GO:0006560) | 2.76093287 |
174 | negative regulation of cell size (GO:0045792) | 2.74194877 |
175 | muscle atrophy (GO:0014889) | 2.73664272 |
176 | antimicrobial humoral response (GO:0019730) | 2.72913226 |
177 | antibacterial humoral response (GO:0019731) | 2.71190324 |
178 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.70747807 |
179 | negative regulation of kidney development (GO:0090185) | 2.70449207 |
180 | sulfate transmembrane transport (GO:1902358) | 2.69758864 |
181 | glucocorticoid biosynthetic process (GO:0006704) | 2.69558813 |
182 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.68023289 |
183 | negative regulation of fatty acid transport (GO:2000192) | 2.67626608 |
184 | negative regulation of cell fate specification (GO:0009996) | 2.67511426 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.67146031 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72365019 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.38250201 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.63659096 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.48187479 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.14402822 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.79614779 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.51626247 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.15894519 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.13807981 |
11 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.92282491 |
12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.85674403 |
13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.77455700 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.59348411 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.39811446 |
16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.35383455 |
17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.35066306 |
18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.31472999 |
19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.24037902 |
20 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.18616728 |
21 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.16122952 |
22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.13715553 |
23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04687237 |
24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.01639913 |
25 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.01134337 |
26 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.99352747 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99015404 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92886055 |
29 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.89799651 |
30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.70138566 |
31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69758954 |
32 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.59628771 |
33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59243366 |
34 | P68_20966046_ChIP-Seq_HELA_Human | 1.54167357 |
35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52090413 |
36 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51052707 |
37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47856174 |
38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47773689 |
39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47711485 |
40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47659005 |
41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47529271 |
42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47066901 |
43 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.43795102 |
44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.43776580 |
45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42888798 |
46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42660571 |
47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41878646 |
48 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39656909 |
49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38753644 |
50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37960862 |
51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35984566 |
52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34584705 |
53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31373408 |
54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30902430 |
55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26939545 |
56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26929089 |
57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25617510 |
58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25097112 |
59 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.24439554 |
60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22811728 |
61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19542282 |
62 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18603498 |
63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17168302 |
64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17114429 |
65 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16683243 |
66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15789710 |
67 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11612499 |
68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10858781 |
69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10490515 |
70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10454229 |
71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08406983 |
72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08074675 |
73 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.07824339 |
74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07309779 |
75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07208303 |
76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06055511 |
77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05395657 |
78 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02888566 |
79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02754464 |
80 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02044240 |
81 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01922898 |
82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00989593 |
83 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.98941405 |
84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98791607 |
85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98764343 |
86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96403291 |
87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94836590 |
88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94746830 |
89 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94463805 |
90 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.94279308 |
91 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93790082 |
92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93569904 |
93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93362854 |
94 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93307678 |
95 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.93108253 |
96 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92887263 |
97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90437029 |
98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88488513 |
99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86924076 |
100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86639380 |
101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85990384 |
102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85261383 |
103 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83936527 |
104 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83637835 |
105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83578711 |
106 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83261039 |
107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81549730 |
108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81516997 |
109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80372515 |
110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80230531 |
111 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79651158 |
112 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77267501 |
113 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77267501 |
114 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75814768 |
115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74667258 |
116 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74458003 |
117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.74380332 |
118 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.73998360 |
119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.73270526 |
120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72499939 |
121 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.72327424 |
122 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71241785 |
123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69394221 |
124 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68527223 |
125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.68439404 |
126 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.68249039 |
127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68089168 |
128 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.67921960 |
129 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.67560096 |
130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.67320574 |
131 | GATA1_22025678_ChIP-Seq_K562_Human | 0.66861887 |
132 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.66519971 |
133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66497173 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.21123353 |
2 | MP0005360_urolithiasis | 5.78099198 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.09561996 |
4 | MP0010234_abnormal_vibrissa_follicle | 4.81609832 |
5 | MP0005365_abnormal_bile_salt | 4.73985574 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.20833836 |
7 | MP0001666_abnormal_nutrient_absorption | 3.82490721 |
8 | MP0003252_abnormal_bile_duct | 3.39229299 |
9 | MP0003806_abnormal_nucleotide_metabolis | 3.32507917 |
10 | MP0005083_abnormal_biliary_tract | 2.93890875 |
11 | MP0010329_abnormal_lipoprotein_level | 2.68838239 |
12 | MP0005377_hearing/vestibular/ear_phenot | 2.43236962 |
13 | MP0003878_abnormal_ear_physiology | 2.43236962 |
14 | MP0004264_abnormal_extraembryonic_tissu | 2.42544996 |
15 | MP0009840_abnormal_foam_cell | 2.38059415 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.31635528 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.22862158 |
18 | MP0003183_abnormal_peptide_metabolism | 2.16375935 |
19 | MP0009379_abnormal_foot_pigmentation | 2.15944145 |
20 | MP0005409_darkened_coat_color | 2.06050646 |
21 | MP0004782_abnormal_surfactant_physiolog | 2.01676087 |
22 | MP0003868_abnormal_feces_composition | 1.98932074 |
23 | MP0004019_abnormal_vitamin_homeostasis | 1.96149065 |
24 | MP0000678_abnormal_parathyroid_gland | 1.94869311 |
25 | MP0005076_abnormal_cell_differentiation | 1.94573001 |
26 | MP0005332_abnormal_amino_acid | 1.89016466 |
27 | MP0002249_abnormal_larynx_morphology | 1.77484790 |
28 | MP0009780_abnormal_chondrocyte_physiolo | 1.74396335 |
29 | MP0005058_abnormal_lysosome_morphology | 1.66868792 |
30 | MP0000462_abnormal_digestive_system | 1.65605867 |
31 | MP0002118_abnormal_lipid_homeostasis | 1.63652699 |
32 | MP0004858_abnormal_nervous_system | 1.59790025 |
33 | MP0009643_abnormal_urine_homeostasis | 1.57967775 |
34 | MP0000609_abnormal_liver_physiology | 1.56734984 |
35 | MP0003879_abnormal_hair_cell | 1.56045145 |
36 | MP0003123_paternal_imprinting | 1.54016958 |
37 | MP0002796_impaired_skin_barrier | 1.53908376 |
38 | MP0010352_gastrointestinal_tract_polyps | 1.50289934 |
39 | MP0003705_abnormal_hypodermis_morpholog | 1.46907869 |
40 | MP0003195_calcinosis | 1.39023595 |
41 | MP0000537_abnormal_urethra_morphology | 1.31860679 |
42 | MP0005084_abnormal_gallbladder_morpholo | 1.29806851 |
43 | MP0003866_abnormal_defecation | 1.29489828 |
44 | MP0010678_abnormal_skin_adnexa | 1.27934305 |
45 | MP0005319_abnormal_enzyme/_coenzyme | 1.27455874 |
46 | MP0001873_stomach_inflammation | 1.27247125 |
47 | MP0000681_abnormal_thyroid_gland | 1.27041250 |
48 | MP0002098_abnormal_vibrissa_morphology | 1.25999847 |
49 | MP0003300_gastrointestinal_ulcer | 1.24349533 |
50 | MP0002254_reproductive_system_inflammat | 1.23115151 |
51 | MP0003453_abnormal_keratinocyte_physiol | 1.22945327 |
52 | MP0000627_abnormal_mammary_gland | 1.20147775 |
53 | MP0005220_abnormal_exocrine_pancreas | 1.18959157 |
54 | MP0010155_abnormal_intestine_physiology | 1.17718026 |
55 | MP0005636_abnormal_mineral_homeostasis | 1.12676897 |
56 | MP0001663_abnormal_digestive_system | 1.10094162 |
57 | MP0005381_digestive/alimentary_phenotyp | 1.08309823 |
58 | MP0000477_abnormal_intestine_morphology | 1.04334715 |
59 | MP0004381_abnormal_hair_follicle | 1.03666252 |
60 | MP0001664_abnormal_digestion | 0.95617148 |
61 | MP0008004_abnormal_stomach_pH | 0.95424760 |
62 | MP0005670_abnormal_white_adipose | 0.95153567 |
63 | MP0005408_hypopigmentation | 0.95102237 |
64 | MP0010030_abnormal_orbit_morphology | 0.90031938 |
65 | MP0009053_abnormal_anal_canal | 0.89978562 |
66 | MP0002132_abnormal_respiratory_system | 0.88783176 |
67 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88042968 |
68 | MP0000427_abnormal_hair_cycle | 0.87111584 |
69 | MP0001727_abnormal_embryo_implantation | 0.86885557 |
70 | MP0000566_synostosis | 0.85140492 |
71 | MP0001765_abnormal_ion_homeostasis | 0.84505313 |
72 | MP0010771_integument_phenotype | 0.82799754 |
73 | MP0001756_abnormal_urination | 0.82562142 |
74 | MP0001764_abnormal_homeostasis | 0.82155325 |
75 | MP0004185_abnormal_adipocyte_glucose | 0.81360232 |
76 | MP0000470_abnormal_stomach_morphology | 0.80258265 |
77 | MP0003283_abnormal_digestive_organ | 0.79040818 |
78 | MP0005666_abnormal_adipose_tissue | 0.78975724 |
79 | MP0002896_abnormal_bone_mineralization | 0.78139626 |
80 | MP0001346_abnormal_lacrimal_gland | 0.77687754 |
81 | MP0002909_abnormal_adrenal_gland | 0.77671916 |
82 | MP0000490_abnormal_crypts_of | 0.77291224 |
83 | MP0002653_abnormal_ependyma_morphology | 0.76562564 |
84 | MP0000538_abnormal_urinary_bladder | 0.76504426 |
85 | MP0005451_abnormal_body_composition | 0.76044690 |
86 | MP0000467_abnormal_esophagus_morphology | 0.75791590 |
87 | MP0003186_abnormal_redox_activity | 0.75736908 |
88 | MP0000613_abnormal_salivary_gland | 0.75476820 |
89 | MP0001849_ear_inflammation | 0.74614929 |
90 | MP0009931_abnormal_skin_appearance | 0.74614854 |
91 | MP0002822_catalepsy | 0.72843784 |
92 | MP0005501_abnormal_skin_physiology | 0.72715918 |
93 | MP0000598_abnormal_liver_morphology | 0.72431441 |
94 | MP0002060_abnormal_skin_morphology | 0.71775529 |
95 | MP0003938_abnormal_ear_development | 0.71208920 |
96 | MP0001881_abnormal_mammary_gland | 0.69939902 |
97 | MP0002089_abnormal_postnatal_growth/wei | 0.69686311 |
98 | MP0003936_abnormal_reproductive_system | 0.69356949 |
99 | MP0002136_abnormal_kidney_physiology | 0.68995938 |
100 | MP0008260_abnormal_autophagy | 0.68154468 |
101 | MP0005375_adipose_tissue_phenotype | 0.67408313 |
102 | MP0009642_abnormal_blood_homeostasis | 0.67009302 |
103 | MP0005310_abnormal_salivary_gland | 0.66375944 |
104 | MP0003566_abnormal_cell_adhesion | 0.63137515 |
105 | MP0009764_decreased_sensitivity_to | 0.62260404 |
106 | MP0004043_abnormal_pH_regulation | 0.62253559 |
107 | MP0005647_abnormal_sex_gland | 0.61964547 |
108 | MP0002928_abnormal_bile_duct | 0.61840667 |
109 | MP0005167_abnormal_blood-brain_barrier | 0.61659714 |
110 | MP0005166_decreased_susceptibility_to | 0.61222300 |
111 | MP0005248_abnormal_Harderian_gland | 0.60838989 |
112 | MP0001216_abnormal_epidermal_layer | 0.59444450 |
113 | MP0002295_abnormal_pulmonary_circulatio | 0.59432697 |
114 | MP0000383_abnormal_hair_follicle | 0.58372177 |
115 | MP0001944_abnormal_pancreas_morphology | 0.57488665 |
116 | MP0008469_abnormal_protein_level | 0.53846083 |
117 | MP0001485_abnormal_pinna_reflex | 0.52556577 |
118 | MP0002876_abnormal_thyroid_physiology | 0.52041831 |
119 | MP0004947_skin_inflammation | 0.50391613 |
120 | MP0002078_abnormal_glucose_homeostasis | 0.50043454 |
121 | MP0003011_delayed_dark_adaptation | 0.49831834 |
122 | MP0000377_abnormal_hair_follicle | 0.49297350 |
123 | MP0005448_abnormal_energy_balance | 0.48905633 |
124 | MP0003656_abnormal_erythrocyte_physiolo | 0.48618758 |
125 | MP0003638_abnormal_response/metabolism_ | 0.48122221 |
126 | MP0009763_increased_sensitivity_to | 0.47862774 |
127 | MP0009765_abnormal_xenobiotic_induced | 0.47542159 |
128 | MP0002277_abnormal_respiratory_mucosa | 0.46658154 |
129 | MP0000604_amyloidosis | 0.46362125 |
130 | MP0009384_cardiac_valve_regurgitation | 0.45163053 |
131 | MP0005023_abnormal_wound_healing | 0.45133414 |
132 | MP0000579_abnormal_nail_morphology | 0.44990753 |
133 | MP0008872_abnormal_physiological_respon | 0.43434685 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 5.86473680 |
2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.53985456 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.44529523 |
4 | Deep venous thrombosis (HP:0002625) | 5.19239242 |
5 | Hypobetalipoproteinemia (HP:0003563) | 4.76004161 |
6 | Xanthomatosis (HP:0000991) | 4.64391556 |
7 | Right ventricular cardiomyopathy (HP:0011663) | 4.60229810 |
8 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.60118851 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 4.48840616 |
10 | Fat malabsorption (HP:0002630) | 4.08712017 |
11 | Chronic bronchitis (HP:0004469) | 4.05839329 |
12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.95174804 |
13 | Distal lower limb muscle weakness (HP:0009053) | 3.83837981 |
14 | Decreased circulating renin level (HP:0003351) | 3.74200912 |
15 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.72088785 |
16 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.72088785 |
17 | Hyperlipoproteinemia (HP:0010980) | 3.71357701 |
18 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.71096285 |
19 | Hypolipoproteinemia (HP:0010981) | 3.69164274 |
20 | Complement deficiency (HP:0004431) | 3.68185686 |
21 | Malnutrition (HP:0004395) | 3.67011340 |
22 | Rhinitis (HP:0012384) | 3.59413561 |
23 | Gout (HP:0001997) | 3.58428811 |
24 | Ileus (HP:0002595) | 3.55708504 |
25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.54642668 |
26 | Hyperammonemia (HP:0001987) | 3.49066786 |
27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.46000557 |
28 | Abnormal ciliary motility (HP:0012262) | 3.45897176 |
29 | Esophageal varix (HP:0002040) | 3.39526294 |
30 | Nasal polyposis (HP:0100582) | 3.39469461 |
31 | Hypoglycemic coma (HP:0001325) | 3.35675779 |
32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.31820698 |
33 | J-shaped sella turcica (HP:0002680) | 3.27389561 |
34 | Hypoalphalipoproteinemia (HP:0003233) | 3.25400881 |
35 | Late onset (HP:0003584) | 3.19014711 |
36 | Ketosis (HP:0001946) | 3.18073286 |
37 | Abnormality of renin-angiotensin system (HP:0000847) | 3.17846202 |
38 | Absent/shortened dynein arms (HP:0200106) | 3.17632035 |
39 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.17632035 |
40 | Hyperglycinuria (HP:0003108) | 3.15554501 |
41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.15356915 |
42 | Abdominal distention (HP:0003270) | 3.15278204 |
43 | Abnormality of the nasal mucosa (HP:0000433) | 3.14370587 |
44 | Abnormality of the common coagulation pathway (HP:0010990) | 3.12616858 |
45 | Abnormality of purine metabolism (HP:0004352) | 3.02995831 |
46 | Thin bony cortex (HP:0002753) | 3.02738596 |
47 | Joint hemorrhage (HP:0005261) | 3.02591137 |
48 | Epidermoid cyst (HP:0200040) | 3.00777238 |
49 | Hypercholesterolemia (HP:0003124) | 2.96924660 |
50 | Amelogenesis imperfecta (HP:0000705) | 2.94764025 |
51 | Hyperparathyroidism (HP:0000843) | 2.94567589 |
52 | Onycholysis (HP:0001806) | 2.93362911 |
53 | Steatorrhea (HP:0002570) | 2.92253567 |
54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91742705 |
55 | Bronchiectasis (HP:0002110) | 2.87854442 |
56 | Hyperactive renin-angiotensin system (HP:0000841) | 2.87213391 |
57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.84040465 |
58 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.83504997 |
59 | Septate vagina (HP:0001153) | 2.81157202 |
60 | Hyperglycinemia (HP:0002154) | 2.80522840 |
61 | Ketoacidosis (HP:0001993) | 2.75870691 |
62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74453664 |
63 | Hyperacusis (HP:0010780) | 2.73281501 |
64 | Abnormality of complement system (HP:0005339) | 2.73040828 |
65 | Abnormality of glycine metabolism (HP:0010895) | 2.72999707 |
66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.72999707 |
67 | Curly hair (HP:0002212) | 2.72428754 |
68 | Abnormal cartilage morphology (HP:0002763) | 2.70935929 |
69 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.67366809 |
70 | Vascular calcification (HP:0004934) | 2.63918431 |
71 | Flat acetabular roof (HP:0003180) | 2.63047777 |
72 | Spinal cord compression (HP:0002176) | 2.59663229 |
73 | Interstitial pulmonary disease (HP:0006530) | 2.57707611 |
74 | Flattened epiphyses (HP:0003071) | 2.57396187 |
75 | Hepatocellular carcinoma (HP:0001402) | 2.56568452 |
76 | Abnormal tarsal ossification (HP:0008369) | 2.52077457 |
77 | Pili torti (HP:0003777) | 2.49036537 |
78 | Hyperphosphatemia (HP:0002905) | 2.46896409 |
79 | Hyperbilirubinemia (HP:0002904) | 2.44980857 |
80 | Abnormality of methionine metabolism (HP:0010901) | 2.44872631 |
81 | Stridor (HP:0010307) | 2.43089605 |
82 | Increased purine levels (HP:0004368) | 2.41358986 |
83 | Hyperuricemia (HP:0002149) | 2.41358986 |
84 | Dicarboxylic aciduria (HP:0003215) | 2.40911297 |
85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40911297 |
86 | Germ cell neoplasia (HP:0100728) | 2.37726823 |
87 | Pustule (HP:0200039) | 2.36714786 |
88 | Micronodular cirrhosis (HP:0001413) | 2.35077994 |
89 | Bell-shaped thorax (HP:0001591) | 2.33496798 |
90 | Renal tubular acidosis (HP:0001947) | 2.33090042 |
91 | Cardiovascular calcification (HP:0011915) | 2.32229344 |
92 | Amyloidosis (HP:0011034) | 2.27442762 |
93 | Metabolic acidosis (HP:0001942) | 2.26443191 |
94 | Lymphangioma (HP:0100764) | 2.26357743 |
95 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.24329592 |
96 | Hyperaldosteronism (HP:0000859) | 2.23635977 |
97 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.23404281 |
98 | Upper limb amyotrophy (HP:0009129) | 2.22125746 |
99 | Distal upper limb amyotrophy (HP:0007149) | 2.22125746 |
100 | Metabolic alkalosis (HP:0200114) | 2.20142580 |
101 | Glomerulosclerosis (HP:0000096) | 2.20127341 |
102 | Fragile nails (HP:0001808) | 2.19364912 |
103 | Growth hormone excess (HP:0000845) | 2.18745640 |
104 | Villous atrophy (HP:0011473) | 2.18369562 |
105 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.18369562 |
106 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.17369329 |
107 | Abnormality of proline metabolism (HP:0010907) | 2.16851164 |
108 | Hydroxyprolinuria (HP:0003080) | 2.16851164 |
109 | Alopecia of scalp (HP:0002293) | 2.16324550 |
110 | Asymmetry of the thorax (HP:0001555) | 2.12782829 |
111 | Concave nail (HP:0001598) | 2.12652340 |
112 | Renal salt wasting (HP:0000127) | 2.12381456 |
113 | Tubulointerstitial fibrosis (HP:0005576) | 2.12073236 |
114 | Lethargy (HP:0001254) | 2.10106534 |
115 | Visceral angiomatosis (HP:0100761) | 2.09469642 |
116 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.09109473 |
117 | Abnormality of vitamin metabolism (HP:0100508) | 2.08694071 |
118 | Palpitations (HP:0001962) | 2.08360933 |
119 | Sensorimotor neuropathy (HP:0007141) | 2.06394297 |
120 | Respiratory distress (HP:0002098) | 2.05574416 |
121 | Pancreatitis (HP:0001733) | 2.05492553 |
122 | Hypoglycemic seizures (HP:0002173) | 2.05444639 |
123 | Potter facies (HP:0002009) | 2.03875207 |
124 | Facial shape deformation (HP:0011334) | 2.03875207 |
125 | Bronchitis (HP:0012387) | 2.03425236 |
126 | Spontaneous abortion (HP:0005268) | 2.03367069 |
127 | Abnormality of the gastric mucosa (HP:0004295) | 2.01120697 |
128 | Abnormality of urine glucose concentration (HP:0011016) | 2.00162831 |
129 | Glycosuria (HP:0003076) | 2.00162831 |
130 | Cervical subluxation (HP:0003308) | 1.99229700 |
131 | Widely patent fontanelles and sutures (HP:0004492) | 1.98213580 |
132 | Severe short stature (HP:0003510) | 1.96954125 |
133 | Dehydration (HP:0001944) | 1.96645532 |
134 | Diaphragmatic weakness (HP:0009113) | 1.96531290 |
135 | Hemorrhage of the eye (HP:0011885) | 1.96084110 |
136 | Flat capital femoral epiphysis (HP:0003370) | 1.94740167 |
137 | Alkalosis (HP:0001948) | 1.94669958 |
138 | Hypotension (HP:0002615) | 1.94256009 |
139 | Systemic lupus erythematosus (HP:0002725) | 1.94074331 |
140 | Abnormality of carpal bone ossification (HP:0006257) | 1.93307265 |
141 | Abnormal hair laboratory examination (HP:0003328) | 1.93157156 |
142 | Hypophosphatemia (HP:0002148) | 1.93064219 |
143 | Acanthocytosis (HP:0001927) | 1.92748956 |
144 | Stroke (HP:0001297) | 1.91489239 |
145 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.91025341 |
146 | Goiter (HP:0000853) | 1.90342562 |
147 | Insulin resistance (HP:0000855) | 1.90158717 |
148 | Delayed CNS myelination (HP:0002188) | 1.89275303 |
149 | Bulbar palsy (HP:0001283) | 1.88477447 |
150 | Woolly hair (HP:0002224) | 1.88427972 |
151 | Tachypnea (HP:0002789) | 1.87608544 |
152 | Abnormal biliary tract morphology (HP:0012440) | 1.86672711 |
153 | Hyponatremia (HP:0002902) | 1.86608492 |
154 | Bronchomalacia (HP:0002780) | 1.86418974 |
155 | Abnormality of chloride homeostasis (HP:0011422) | 1.85287104 |
156 | Abnormal vertebral ossification (HP:0100569) | 1.83628294 |
157 | Myocardial infarction (HP:0001658) | 1.83485655 |
158 | Hemangiomatosis (HP:0007461) | 1.82881001 |
159 | Symptomatic seizures (HP:0011145) | 1.80987739 |
160 | Ulnar claw (HP:0001178) | 1.80908285 |
161 | Hypercalciuria (HP:0002150) | 1.80677834 |
162 | Taurodontia (HP:0000679) | 1.80571283 |
163 | Abnormality of permanent molar morphology (HP:0011071) | 1.80571283 |
164 | Abnormality of the dental root (HP:0006486) | 1.80571283 |
165 | Progressive sensorineural hearing impairment (HP:0000408) | 1.79530741 |
166 | Focal segmental glomerulosclerosis (HP:0000097) | 1.78841654 |
167 | Congenital glaucoma (HP:0001087) | 1.76652209 |
168 | Atelectasis (HP:0100750) | 1.74314233 |
169 | Adrenal overactivity (HP:0002717) | 1.72924914 |
170 | Chronic sinusitis (HP:0011109) | 1.72230981 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK1 | 5.35021616 |
2 | EPHA2 | 4.12660292 |
3 | MST1R | 3.40262393 |
4 | FRK | 3.29575391 |
5 | ARAF | 3.06099792 |
6 | TAOK3 | 2.92887435 |
7 | BCKDK | 2.69802270 |
8 | SMG1 | 2.69010459 |
9 | MAP2K2 | 2.67457249 |
10 | ERN1 | 2.66256380 |
11 | EPHB2 | 2.39598107 |
12 | LMTK2 | 2.36917243 |
13 | PIK3CA | 2.31964736 |
14 | PIM2 | 2.17427480 |
15 | MST4 | 2.10432483 |
16 | MAP3K2 | 2.07883427 |
17 | MAP3K3 | 2.06434895 |
18 | SIK1 | 2.03904320 |
19 | PTK6 | 1.88834886 |
20 | FGFR4 | 1.86893468 |
21 | MAPK15 | 1.84050132 |
22 | MUSK | 1.73880383 |
23 | TRIB3 | 1.71992087 |
24 | TAOK1 | 1.56298255 |
25 | TESK1 | 1.47869805 |
26 | PRKG2 | 1.44245990 |
27 | TESK2 | 1.42046289 |
28 | FER | 1.41099970 |
29 | NME2 | 1.35272754 |
30 | MYLK | 1.34645658 |
31 | MAP3K11 | 1.30486374 |
32 | LATS1 | 1.25863460 |
33 | DDR2 | 1.24207985 |
34 | BRAF | 1.23768681 |
35 | MET | 1.22274913 |
36 | INSRR | 1.20462784 |
37 | RPS6KB2 | 1.18706642 |
38 | PTK2 | 1.16247203 |
39 | NEK6 | 1.13013239 |
40 | PKN2 | 1.08878578 |
41 | PRKCI | 1.08085033 |
42 | NME1 | 1.07359727 |
43 | MAP2K1 | 1.03285045 |
44 | AKT3 | 1.02150546 |
45 | MATK | 1.01208678 |
46 | ERBB2 | 0.99934343 |
47 | EPHB1 | 0.99001833 |
48 | MAP2K6 | 0.96558828 |
49 | GRK6 | 0.93453901 |
50 | DAPK2 | 0.93084423 |
51 | DYRK1B | 0.91239278 |
52 | ILK | 0.90216558 |
53 | CAMK2G | 0.87462905 |
54 | STK38L | 0.85663018 |
55 | MAP2K3 | 0.84819326 |
56 | ACVR1B | 0.84482348 |
57 | PRKD2 | 0.78443463 |
58 | MAP3K1 | 0.78290798 |
59 | ICK | 0.74622076 |
60 | GSK3A | 0.71783835 |
61 | PIK3CG | 0.70023607 |
62 | ERBB4 | 0.67641352 |
63 | MAPK11 | 0.67030807 |
64 | PAK4 | 0.66067692 |
65 | TAOK2 | 0.64909837 |
66 | SCYL2 | 0.63325678 |
67 | TBK1 | 0.62775976 |
68 | EPHA3 | 0.62634768 |
69 | KSR2 | 0.61471216 |
70 | STK24 | 0.60058279 |
71 | MTOR | 0.59397502 |
72 | CSK | 0.59381884 |
73 | MAP3K10 | 0.58823950 |
74 | CDC42BPA | 0.58068362 |
75 | GRK1 | 0.57606224 |
76 | RET | 0.57566622 |
77 | CAMK2D | 0.56059241 |
78 | DMPK | 0.55109363 |
79 | MAPKAPK3 | 0.53598982 |
80 | IRAK3 | 0.53092427 |
81 | NUAK1 | 0.53016863 |
82 | WNK4 | 0.52853248 |
83 | PRPF4B | 0.52145089 |
84 | LRRK2 | 0.48694898 |
85 | PDGFRA | 0.47633840 |
86 | FGFR2 | 0.47484091 |
87 | STK38 | 0.47318965 |
88 | EEF2K | 0.45262709 |
89 | VRK2 | 0.44570777 |
90 | MAP3K7 | 0.43506669 |
91 | MAP3K12 | 0.43416423 |
92 | MAP3K8 | 0.41786446 |
93 | SIK3 | 0.41710293 |
94 | CAMK2B | 0.41621559 |
95 | RPS6KA2 | 0.41171769 |
96 | PDK1 | 0.40992953 |
97 | HIPK2 | 0.40641646 |
98 | RPS6KL1 | 0.40568698 |
99 | RPS6KC1 | 0.40568698 |
100 | TGFBR2 | 0.40195495 |
101 | TYK2 | 0.39941989 |
102 | PRKD1 | 0.39238468 |
103 | STK39 | 0.37124613 |
104 | LIMK1 | 0.36440272 |
105 | PDPK1 | 0.36177030 |
106 | PRKAA2 | 0.34973882 |
107 | MAPKAPK2 | 0.34950791 |
108 | MARK2 | 0.34267623 |
109 | ABL2 | 0.33604868 |
110 | NEK9 | 0.32520310 |
111 | RAF1 | 0.32040091 |
112 | RPS6KA6 | 0.30844233 |
113 | IKBKE | 0.30336582 |
114 | MAP3K14 | 0.29794154 |
115 | PRKCZ | 0.29190679 |
116 | TNK2 | 0.28993550 |
117 | STK10 | 0.28207291 |
118 | CDK6 | 0.27052442 |
119 | CHUK | 0.26289577 |
120 | RPS6KA1 | 0.25538344 |
121 | CAMKK1 | 0.25157277 |
122 | CDK7 | 0.25055414 |
123 | MELK | 0.24982101 |
124 | PRKCD | 0.24746633 |
125 | PRKCQ | 0.23774196 |
126 | IRAK2 | 0.23495011 |
127 | BMX | 0.22687753 |
128 | TLK1 | 0.22159237 |
129 | IRAK1 | 0.20778719 |
130 | IKBKB | 0.20433710 |
131 | JAK2 | 0.19956067 |
132 | KDR | 0.19514497 |
133 | PDGFRB | 0.18856996 |
134 | PAK3 | 0.18815514 |
135 | DAPK3 | 0.18769029 |
136 | CSNK1A1 | 0.18705317 |
137 | SRC | 0.18110157 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.76521961 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.27195315 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.22070532 |
4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.70711059 |
5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58166861 |
6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.55886497 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47754153 |
8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.46797741 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44175854 |
10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.41828056 |
11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.30662634 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28453369 |
13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.22085727 |
14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.19910964 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13449038 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.02068437 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96876122 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.94398012 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.88015527 |
20 | Bile secretion_Homo sapiens_hsa04976 | 1.82683110 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.82085345 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78559842 |
23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74811521 |
24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72808079 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70494825 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70055279 |
27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.69894717 |
28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69854207 |
29 | Peroxisome_Homo sapiens_hsa04146 | 1.64931863 |
30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62463844 |
31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53106269 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47502585 |
33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38128441 |
34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37426458 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35563553 |
36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33816629 |
37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30690741 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29367629 |
39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28875658 |
40 | Mineral absorption_Homo sapiens_hsa04978 | 1.28033795 |
41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26079936 |
42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.23644864 |
43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23531034 |
44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23375803 |
45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14901049 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.14607873 |
47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08433541 |
48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04268339 |
49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.04190946 |
50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02895458 |
51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00459897 |
52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99751230 |
53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97490694 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96919420 |
55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95307735 |
56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92141632 |
57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92105091 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89446489 |
59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89090821 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88692980 |
61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85133293 |
62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83839917 |
63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83674562 |
64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82582159 |
65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81564527 |
66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78374458 |
67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76098486 |
68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75944773 |
69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75428290 |
70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75232262 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73460980 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73332489 |
73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71914510 |
74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70641723 |
75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66036263 |
76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64814016 |
77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61837172 |
78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60868300 |
79 | Bladder cancer_Homo sapiens_hsa05219 | 0.52487697 |
80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52233111 |
81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51876150 |
82 | * Tight junction_Homo sapiens_hsa04530 | 0.49786309 |
83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47677808 |
84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45928812 |
85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45723941 |
86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43547594 |
87 | Lysosome_Homo sapiens_hsa04142 | 0.43214317 |
88 | Lysine degradation_Homo sapiens_hsa00310 | 0.42135876 |
89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41637957 |
90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40738328 |
91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38005443 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37433833 |
93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37169036 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36498455 |
95 | * Hepatitis C_Homo sapiens_hsa05160 | 0.35792426 |
96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35120123 |
97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34508063 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33669720 |
99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31716052 |
100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30413028 |
101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28757218 |
102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26595017 |
103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.23963907 |
104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23679453 |
105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.20785602 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20379420 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19234869 |
108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18706078 |
109 | Adherens junction_Homo sapiens_hsa04520 | 0.18007984 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.17903301 |
111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17392499 |
112 | Prostate cancer_Homo sapiens_hsa05215 | 0.16753543 |
113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16450907 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.16376960 |
115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.16037532 |
116 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.10703485 |
117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.08593368 |
118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.08132919 |
119 | Amoebiasis_Homo sapiens_hsa05146 | 0.04433482 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03838802 |
121 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.01587207 |
122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00315566 |
123 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0276558 |
124 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0127942 |
125 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0062018 |